The U.S. Drug Enforcement Administration (DEA) is temporarily extending the Schedule I status of synthetic cannabinoid N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (MAB-CHMINACA), including its optical, positional and geometric isomers, salts, and … Read More
The post DEA temporarily extends Schedule I status of synthetic cannabinoid appeared first on Dagga Magazine.